The U.S. pharmaceutical industry seeks to alter Medicare drug price negotiation laws under Trump's return. China approves ...
Sarah Sammons, MD, discusses some of the challenges seen with different regimens for HER2-positive metastatic breast cancer ...
China: Enhertu, a blockbuster breast cancer drug of AstraZeneca, will be included in China's state-run health insurance ...
The latest health news includes studies on medications for thyroid issues and breast cancer, the healthcare industry's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback